Vitamin A and Retinoid Derivatives for Lung Cancer: A Systematic Review and Meta Analysis

被引:58
作者
Fritz, Heidi [1 ]
Kennedy, Deborah [1 ,2 ]
Fergusson, Dean
Fernandes, Rochelle [1 ,3 ]
Doucette, Steve
Cooley, Kieran [1 ,2 ]
Seely, Andrew [4 ]
Sagar, Stephen [5 ]
Wong, Raimond [5 ]
Seely, Dugald [1 ]
机构
[1] Canadian Coll Naturopath Med, Dept Res & Epidemiol, Toronto, ON, Canada
[2] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada
[3] Univ Toronto, Lab Med & Pathobiol LMP, Toronto, ON, Canada
[4] Ottawa Hosp Res Inst, Dept Surg, Ottawa, ON, Canada
[5] McMaster Univ, Dept Med, Juravinski Canc Ctr, Hamilton, ON, Canada
基金
加拿大健康研究院;
关键词
BETA-CAROTENE SUPPLEMENTATION; SQUAMOUS-CELL CARCINOMA; CHEMOTHERAPY-NAIVE PATIENTS; BASE-LINE CHARACTERISTICS; GROWTH-FACTOR RECEPTOR; 2ND PRIMARY TUMORS; 13-CIS-RETINOIC ACID; ALPHA-TOCOPHEROL; EFFICACY TRIAL; HIGH-RISK;
D O I
10.1371/journal.pone.0021107
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
070301 [无机化学]; 070403 [天体物理学]; 070507 [自然资源与国土空间规划学]; 090105 [作物生产系统与生态工程];
摘要
Background: Despite reported antiproliferative activity of vitamin A and its common use for cancer, there is no comprehensive synthesis of its safety and efficacy in lung cancers. To address this issue we conducted a systematic review of the safety and efficacy of vitamin A for the treatment and prevention of lung cancers. Methods and Findings: Two independent reviewers searched six electronic databases from inception to July 2009 for clinical, observational, and preclinical evidence pertaining to the safety and efficacy of vitamin A and related retinoids for lung cancers. 248 studies were included for full review and analysis. Five RCTs assessed treatment of lung cancers, three assessed primary prevention, and three looked at secondary prevention of lung cancers. Five surrogate studies, 26 phase I/II, 32 observational, and 67 preclinical studies were also included. 107 studies were included for interactions between vitamin A and chemo- or radiation-therapy. Although some studies demonstrated benefits, there was insufficient evidence overall to support the use of vitamin A or related retinoids for the treatment or prevention of lung cancers. Retinyl palmitate combined with beta carotene increased risk of lung cancer in smokers in the large CARET trial. Pooling of three studies pertaining to treatment and three studies on secondary prevention revealed no significant effects on response rate, second primary tumor, recurrence, 5-year survival, and mortality. There was a small improvement in event free survival associated with vitamin A compared to controls, RR 1.24 (95% CI 1.13-1.35). The synthetic rexinoid bexarotene increased survival significantly among a subset of patients in two RCTs (p<0.014, <0.087). Conclusions: There is a lack of evidence to support the use of naturally occuring retinoids for the treatment and prevention of lung cancers. The rexinoid bexarotene may hold promise for use among a subset of patients, and deserves further study.
引用
收藏
页数:11
相关论文
共 102 条
[1]
Control of oxidative phosphorylation by vitamin A illuminates a fundamental role in mitochondrial energy homoeostasis [J].
Acin-Perez, Rebeca ;
Hoyos, Beatrice ;
Zhao, Feng ;
Vinogradov, Valerie ;
Fischman, Donald A. ;
Harris, Robert A. ;
Leitges, Michael ;
Wongsiriroj, Nuttaporn ;
Blaner, William S. ;
Manfredi, Giovanni ;
Hammerling, Ulrich .
FASEB JOURNAL, 2010, 24 (02) :627-636
[2]
alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: Effects of base-line characteristics and study compliance [J].
Albanes, D ;
Heinonen, OP ;
Taylor, PR ;
Virtamo, J ;
Edwards, BK ;
Rautalahti, M ;
Hartman, AM ;
Palmgren, J ;
Freedman, LS ;
Haapakoski, J ;
Barrett, MJ ;
Pietinen, P ;
Malila, N ;
Tala, E ;
Liippo, K ;
Salomaa, ER ;
Tangrea, JA ;
Teppo, L ;
Askin, FB ;
Taskinen, E ;
Erozan, Y ;
Greenwald, P ;
Huttunen, JK .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (21) :1560-1570
[3]
Effects of supplemental beta-carotene, cigarette smoking, and alcohol consumption on serum carotenoids in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study [J].
Albanes, D ;
Virtamo, J ;
Taylor, PR ;
Rautalahti, M ;
Pietinen, P ;
Heinonen, OP .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1997, 66 (02) :366-372
[4]
Epidemiology of lung cancer: Looking to the future [J].
Alberg, AJ ;
Brock, MV ;
Samet, JM .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (14) :3175-3185
[5]
The revised CONSORT statement for reporting randomized trials: Explanation and elaboration [J].
Altman, DG ;
Schulz, KF ;
Moher, D ;
Egger, M ;
Davidoff, F ;
Elbourne, D ;
Gotzsche, PC ;
Lang, T .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) :663-694
[6]
*AM CANC SOC, 2010, CANC REF INF WHAT AR
[7]
Amitabha R., 2005, Indian Journal of Cancer, V42, P15
[8]
Bexarotene in combination with chemotherapy fails to prolong survival in patients with advanced non-small-cell lung cancer: Results from the SPIRIT I and II trials [J].
不详 .
CLINICAL LUNG CANCER, 2005, 7 (01) :17-19
[9]
[Anonymous], 1982, EUR J BIOCHEM, V129, P1
[10]
[Anonymous], COCHRANE DATABASE SY